Thalidomide-O-amido-C6-NH2 TFA
CAS No. 1950635-14-9
Thalidomide-O-amido-C6-NH2 TFA ( Cereblon Ligand-Linker Conjugates 11 TFA | E3 Ligase Ligand-Linker Conjugates 25 TFA | E3 Ligase Ligand-Linker Conjugates 25 Trifluoroacetate | Thalidomide-O-amido-C6-NH2 TFA )
产品货号. M26948 CAS No. 1950635-14-9
沙利度胺-O-酰胺基-C6-NH2 TFA,一种合成的 E3 连接酶配体-接头缀合物,含有基于沙利度胺的 cereblon 配体和接头。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥381 | 有现货 |
|
5MG | ¥624 | 有现货 |
|
10MG | ¥915 | 有现货 |
|
25MG | ¥1531 | 有现货 |
|
50MG | ¥2252 | 有现货 |
|
100MG | ¥3532 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Thalidomide-O-amido-C6-NH2 TFA
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述沙利度胺-O-酰胺基-C6-NH2 TFA,一种合成的 E3 连接酶配体-接头缀合物,含有基于沙利度胺的 cereblon 配体和接头。
-
产品描述Thalidomide-O-amido-C6-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate containing a Thalidomide-based cereblon ligand and a linker.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
体外实验PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
体内实验——
-
同义词Cereblon Ligand-Linker Conjugates 11 TFA | E3 Ligase Ligand-Linker Conjugates 25 TFA | E3 Ligase Ligand-Linker Conjugates 25 Trifluoroacetate | Thalidomide-O-amido-C6-NH2 TFA
-
通路Others
-
靶点Other Targets
-
受体DNA replication| HCMV| Nucleoside Analogue
-
研究领域——
-
适应症——
化学信息
-
CAS Number1950635-14-9
-
分子量544.484
-
分子式C23H27F3N4O8
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (183.66 mM)
-
SMILESOC(=O)C(F)(F)F.NCCCCCCNC(=O)COc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Hamada A, et al. Clinical pharmacokinetics of cytarabine formulations.Clin Pharmacokinet. 2002;41(10):705-18.
产品手册
关联产品
-
IMP-1088
IMP-1088 是人 N-肉豆蔻酰转移酶 NMT1 和 NMT2 双重的有效抑制剂。
-
4-(benzyloxy)benzene...
4-(benzyloxy)苯-1-sulfonamide 是人重组 CA-7 的抑制剂。
-
Tricarballylic acid
三羧基酸是乌头酸酶的抑制剂。